Results 181 to 190 of about 465,656 (285)

WCN25-3817 LOIN PAIN IN RARE KIDNEY DISEASE: ANALYSIS OF 3867 QUESTIONNAIRE RESPONSES WITH LINKED DATA FROM THE UK NATIONAL REGISTRY OF RARE KIDNEY DISEASES (RaDaR)

open access: yesKidney International Reports
Katie Wong   +7 more
doaj   +1 more source

Development of Celiac Disease After Immunotherapy: A Case Series. [PDF]

open access: yesGastro Hep Adv
Malick A   +4 more
europepmc   +1 more source

Gene expression and metabolic variability in fungus‐resistant PIWI (‘Pilzwiderstandsfähig’) grape cultivars

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract BACKGROUND Fungus‐resistant PIWI (Pilzwiderstandsfähig) grape cultivars are promising for reducing pesticide inputs in viticulture, but their enological potential is still poorly characterized. We performed a pilot, single‐vintage study integrating berry gene expression and phenolic composition in five Italian red PIWI cultivars (Cabernet ...
Villano Clizia   +8 more
wiley   +1 more source

Predictive Value of tTG-IgA ≥ 10×ULN for Villous Atrophy in a Romanian Adult Cohort: The Modifying Role of Smoking. [PDF]

open access: yesDiagnostics (Basel)
Nemteanu R   +12 more
europepmc   +1 more source

Oral PHGG ameliorates atopic dermatitis‐like dermatitis with concurrent modulation of colonic IgA and cecal microbiota: implications for the gut–skin axis

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract BACKGROUND Atopic dermatitis (AD) is increasingly recognized as a systemic inflammatory disorder linked to intestinal immune and microbiome dysregulation. However, whether dietary galactomannan fibers can mitigate AD through coordinated modulation of the gut–skin axis remains unexplored.
Derrick Kakooza   +6 more
wiley   +1 more source

Impaired mucosal IgA response to SARS-CoV-2 in patients with inborn errors of immunity. [PDF]

open access: yesFront Immunol
Zuo F   +10 more
europepmc   +1 more source

Clinically Meaningful Improvements in Quality of Life, Including Sleep, With Two‐Week and Monthly Dosed Rademikibart: A Phase 2 Randomized Trial in Adults With Moderate‐to‐Severe Atopic Dermatitis

open access: yesJEADV Clinical Practice, EarlyView.
Rademikibart, a potent IL‐4Rα‐targeting antibody, achieved its primary endpoint as a treatment for adults with moderate‐to‐severe atopic dermatitis (AD) in the CBP‐201‐WW001 Phase 2 trial. There is a need for AD treatment options with convenient dosing intervals.
Jonathan I. Silverberg   +2 more
wiley   +1 more source

Familial patterns of immune dysregulation in CVID: insights from B- and T-cell phenotyping and antibody profiling. [PDF]

open access: yesFront Immunol
Comans SET   +11 more
europepmc   +1 more source

Buccal Mucosa as Substrate for Direct Immunofluorescence Should Be Included Early in the Diagnostic Work Up of Ocular Mucous Membrane Pemphigoid

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background In ocular mucous membrane pemphigoid (MMP) direct immunofluorescence (DIF) represents the gold standard for definitive diagnosis. However, up to 50% of ocular MMP cases do not meet the immunopathological criteria. In addition, the risk of exacerbating conjunctival cicatrization makes ocular biopsy technically difficult to obtain ...
Andrea Gabusi   +6 more
wiley   +1 more source

Disruption of IgA-mediated aggregation at weaning favors mucus encroachment by commensal bacteria. [PDF]

open access: yesNPJ Biofilms Microbiomes
Simpson K   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy